Ironwood Pharmaceuticals, Inc.
IRWD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $1 | $1 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | $1 | $2 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -20.6% | 7.8% | -0.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 97.9% | 98.6% | 99.7% | 83% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 27.8% | 44.6% | 63.7% | 56.5% |
| Net Income | $0 | -$1 | $0 | $1 |
| % Margin | 0.3% | -226.4% | 42.6% | 127.7% |
| EPS Diluted | 0.006 | -6.45 | 0.96 | 3.21 |
| % Growth | 100.1% | -771.9% | -70.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |